Upstream Medical Technologies, which is developing novel biomarkers for heart disease, has raised $2 million in its latest capital round to take it from discovery to commercial development.
The $2m investment was led by existing deep tech investor Pacific Channel and included $262,500 from new
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
